Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 231

1.

Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.

Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ.

Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):121-6.

PMID:
8850273
[PubMed - indexed for MEDLINE]
Free Article
2.

Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.

Ma J, Stampfer MJ, Gann PH, Hough HL, Giovannucci E, Kelsey KT, Hennekens CH, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):385-90.

PMID:
9610787
[PubMed - indexed for MEDLINE]
Free Article
3.

Prospective study of sex hormone levels and risk of prostate cancer.

Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ.

J Natl Cancer Inst. 1996 Aug 21;88(16):1118-26.

PMID:
8757191
[PubMed - indexed for MEDLINE]
Free Article
4.

Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)

Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW.

Cancer Causes Control. 1995 May;6(3):235-9.

PMID:
7612803
[PubMed - indexed for MEDLINE]
5.

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.

Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1991-7.

PMID:
16103450
[PubMed - indexed for MEDLINE]
Free Article
6.

Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.

Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ.

Cancer Res. 1999 Mar 15;59(6):1225-30.

PMID:
10096552
[PubMed - indexed for MEDLINE]
Free Article
7.

Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.

Jacobs ET, Giuliano AR, Martínez ME, Hollis BW, Reid ME, Marshall JR.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):533-7.

PMID:
15225833
[PubMed - indexed for MEDLINE]
8.

Calcium intake and prostate cancer risk in a long-term aging study: the Baltimore Longitudinal Study of Aging.

Berndt SI, Carter HB, Landis PK, Tucker KL, Hsieh LJ, Metter EJ, Platz EA; Baltimore Longitudinal Study of Aging.

Urology. 2002 Dec;60(6):1118-23.

PMID:
12475694
[PubMed - indexed for MEDLINE]
9.

A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.

Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, Giovannucci EL, Ma J.

PLoS Med. 2007 Mar;4(3):e103.

PMID:
17388667
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.

Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A.

JAMA. 2006 Dec 20;296(23):2832-8.

PMID:
17179460
[PubMed - indexed for MEDLINE]
11.

Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men.

Barnett CM, Nielson CM, Shannon J, Chan JM, Shikany JM, Bauer DC, Hoffman AR, Barrett-Connor E, Orwoll E, Beer TM.

Cancer Causes Control. 2010 Aug;21(8):1297-303. doi: 10.1007/s10552-010-9557-y. Epub 2010 Apr 10.

PMID:
20383574
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Plasma vitamin D metabolites and risk of colorectal cancer in women.

Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, Giovannucci EL.

Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1502-8.

PMID:
15342452
[PubMed - indexed for MEDLINE]
Free Article
13.

Vitamin D and prostate cancer: a prediagnostic study with stored sera.

Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N.

Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):467-72.

PMID:
8220092
[PubMed - indexed for MEDLINE]
Free Article
14.

Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.

Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E.

Cancer Causes Control. 2004 Apr;15(3):255-65.

PMID:
15090720
[PubMed - indexed for MEDLINE]
15.

Vasectomy and prostate cancer: a case-control study in India.

Platz EA, Yeole BB, Cho E, Jussawalla DJ, Giovannucci E, Ascherio A.

Int J Epidemiol. 1997 Oct;26(5):933-8.

PMID:
9363512
[PubMed - indexed for MEDLINE]
Free Article
16.

Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States)

Nomura AM, Stemmermann GN, Lee J, Kolonel LN, Chen TC, Turner A, Holick MF.

Cancer Causes Control. 1998 Aug;9(4):425-32.

PMID:
9794175
[PubMed - indexed for MEDLINE]
17.

Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer.

Tuohimaa P, Tenkanen L, Syvälä H, Lumme S, Hakulinen T, Dillner J, Hakama M.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):302-7.

PMID:
17301263
[PubMed - indexed for MEDLINE]
Free Article
18.

A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.

Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL.

J Natl Cancer Inst. 2007 Jul 18;99(14):1120-9. Epub 2007 Jul 10.

PMID:
17623801
[PubMed - indexed for MEDLINE]
Free Article
19.

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, Giovannucci E.

J Natl Cancer Inst. 2002 Jul 17;94(14):1099-106.

PMID:
12122101
[PubMed - indexed for MEDLINE]
Free Article
20.

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.

Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M.

Science. 1998 Jan 23;279(5350):563-6.

PMID:
9438850
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk